Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Ariavax

2000 FOUNDED
PRIVATE STATUS
Grant LATEST DEAL TYPE
$556K LATEST DEAL AMOUNT
2 INVESTORS
Description

Developer of a vaccine against urinary tract infection. The company's vaccines are based on its proprietary peptide chemistry technology.

Website
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Drug Discovery
Primary Office
  • 708 Quince Orchard Road
  • Gaithersburg, MD 20878
  • United States

+1 (240) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Ariavax’s full profile, request a free trial.

Ariavax Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Grant 01-Feb-2009 $556K Completed Generating Revenue
2. Grant 01-May-2005 00000 Completed Generating Revenue
1. Accelerator/Incubator Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Ariavax Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Maryland Industrial Partnerships Accelerator/Incubator 000 0000 000000 0
TEDCO Venture Capital Minority 000 0000 000000 0